ES2194992T3 - Procedimientos para la incorporacion estable de sustancias en matrices vitreas secas esponjosas, y composiciones asi obtenidas. - Google Patents

Procedimientos para la incorporacion estable de sustancias en matrices vitreas secas esponjosas, y composiciones asi obtenidas.

Info

Publication number
ES2194992T3
ES2194992T3 ES96917569T ES96917569T ES2194992T3 ES 2194992 T3 ES2194992 T3 ES 2194992T3 ES 96917569 T ES96917569 T ES 96917569T ES 96917569 T ES96917569 T ES 96917569T ES 2194992 T3 ES2194992 T3 ES 2194992T3
Authority
ES
Spain
Prior art keywords
compositions
substances
procedures
vitreas
matrices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96917569T
Other languages
English (en)
Inventor
Bruce Joseph Roser
Enda Martin Gribbon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Drug Delivery Ltd
Original Assignee
Elan Drug Delivery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23930384&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2194992(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elan Drug Delivery Ltd filed Critical Elan Drug Delivery Ltd
Application granted granted Critical
Publication of ES2194992T3 publication Critical patent/ES2194992T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION DESCRIBE PROCEDIMIENTOS PARA PRODUCIR VIDRIO CELULAR Y LAS COMPOSICIONES QUE SE OBTIENEN MEDIANTE ESTOS. LAS COMPOSICIONES RESULTAN ADECUADAS PARA EL ALMACENAJE ESTABLE DE UNA AMPLIA DIVERSIDAD DE SUSTANCIAS, EN PARTICULAR BIOLOGICAS Y FARMACEUTICAS.
ES96917569T 1995-06-07 1996-06-07 Procedimientos para la incorporacion estable de sustancias en matrices vitreas secas esponjosas, y composiciones asi obtenidas. Expired - Lifetime ES2194992T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48604395A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
ES2194992T3 true ES2194992T3 (es) 2003-12-01

Family

ID=23930384

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96917569T Expired - Lifetime ES2194992T3 (es) 1995-06-07 1996-06-07 Procedimientos para la incorporacion estable de sustancias en matrices vitreas secas esponjosas, y composiciones asi obtenidas.

Country Status (22)

Country Link
EP (1) EP0831790B1 (es)
JP (1) JP4502406B2 (es)
KR (1) KR19990022710A (es)
CN (1) CN1245957C (es)
AP (1) AP852A (es)
AT (1) ATE239451T1 (es)
AU (1) AU713599B2 (es)
BR (1) BR9609188A (es)
CA (1) CA2223438C (es)
CZ (1) CZ391297A3 (es)
DE (1) DE69628007T2 (es)
DK (1) DK0831790T3 (es)
ES (1) ES2194992T3 (es)
HU (1) HUP9901716A3 (es)
IL (1) IL122482A (es)
MX (1) MX9709716A (es)
NO (1) NO975773L (es)
NZ (1) NZ309841A (es)
PL (1) PL184823B1 (es)
PT (1) PT831790E (es)
SK (1) SK167597A3 (es)
WO (1) WO1996040077A2 (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2194911T3 (es) 1994-06-02 2003-12-01 Elan Drug Delivery Ltd Metodo para evitar la agregacion de proteinas/peptidos cuando tiene lugar su rehidratacion o descongelacion.
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US6509146B1 (en) 1996-05-29 2003-01-21 Universal Preservation Technologies, Inc. Scalable long-term shelf preservation of sensitive biological solutions and suspensions
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
GB9705588D0 (en) 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
JP2001524306A (ja) * 1997-11-26 2001-12-04 ユニバーサル プリザーベーション テクノロジーズ インコーポレイテッド ガラス化による不安定な生物学的サンプルの保存
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
AU2945199A (en) * 1998-03-18 1999-10-11 Ronai, Peter Amorphous glasses for stabilising sensitive products
US6306345B1 (en) 1998-05-06 2001-10-23 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
JP2011025068A (ja) * 1999-02-22 2011-02-10 Chugai Pharmaceut Co Ltd プレフィルドシリンジタンパク質溶液製剤
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
MXPA01011145A (es) * 1999-05-04 2003-07-14 Anhydro Ltd Metodo para la conservacion de virus y micoplasma.
US6692695B1 (en) 1999-05-06 2004-02-17 Quadrant Drug Delivery Limited Industrial scale barrier technology for preservation of sensitive biological materials
GB9914412D0 (en) * 1999-06-22 1999-08-18 Worrall Eric E Method for the preservation of viruses,bacteria and biomolecules
WO2001012779A1 (en) * 1999-08-19 2001-02-22 Universal Preservation Technologies, Inc. Preservation of bacterial cells at ambient temperatures
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AU2001281846B2 (en) 2000-06-27 2006-04-27 Cheplapharm Arzneimittel Gmbh Method for preparing a composition
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US6653062B1 (en) 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
US6537666B1 (en) 2000-10-23 2003-03-25 Universal Preservation Technologies, Inc. Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals
WO2003041637A2 (en) * 2001-11-09 2003-05-22 Centocor, Inc. Lyophilized monoclonal antibody compositions
EP1458360B1 (en) 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides
AU2003287980B2 (en) * 2002-11-01 2009-06-25 Glaxosmithkline Biologicals S.A. Drying process
EP1428526A1 (en) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
GB0409795D0 (en) 2004-04-30 2004-06-09 Glaxosmithkline Biolog Sa Drying method
JP2008509226A (ja) 2004-05-24 2008-03-27 ジェンボールト コーポレイション 回収可能な形式での安定なタンパク質保管および安定な核酸保管
ES2644416T3 (es) 2004-06-02 2017-11-28 Universal Stabilization Technologies, Inc. Conservación mediante vaporización
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
GB0523638D0 (en) * 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
JP5214464B2 (ja) * 2005-12-28 2013-06-19 アドバンスド バイオニュートリション コーポレーション 多糖類、糖類およびポリオール類の乾燥マトリックスを含む、ガラス形態の、プロバイオティクス細菌用送達媒体およびその製造方法
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
BRPI0814594A2 (pt) 2007-07-26 2015-01-20 Sanofi Pasteur Ltd Composições e métodos adjuvantes de antígeno
CN102177237B (zh) 2008-09-12 2013-10-30 金沃特公司 用于贮存和稳定生物分子的基质和介质
US9623094B2 (en) 2009-03-27 2017-04-18 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
SG176253A1 (en) 2009-05-26 2011-12-29 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
CA2785815C (en) 2010-01-28 2018-04-24 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CA2807997C (en) * 2010-08-13 2015-11-17 Advanced Bionutrition Corporation Dry storage stabilizing composition for biological materials
WO2012116280A2 (en) * 2011-02-24 2012-08-30 Paxvax, Inc. Formulations useful for spray drying vaccines
DK2709657T3 (en) * 2011-05-17 2019-01-14 Soligenix Inc Thermostable vaccine compositions and methods for their preparation
WO2013063284A1 (en) 2011-10-25 2013-05-02 Onclave Therapeutics Antibody formulations and methods
GB2498774A (en) 2012-01-27 2013-07-31 Bruce Roser Glass-stabilised biological materials and syringe
PT3328215T (pt) 2015-07-29 2021-08-03 Advanced Bionutrition Corp Composições probióticas estáveis secas para utilizações dietéticas especiais
ES2963004T3 (es) * 2015-09-09 2024-03-22 Drawbridge Health Inc Dispositivos para la recopilación, estabilización y conservación de muestras
CN106434840B (zh) * 2016-12-02 2019-08-09 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测维生素b12的微孔板、其试剂盒及其制备方法
CN106701887B (zh) * 2017-01-03 2020-01-17 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测叶酸的微孔板、其试剂盒及其制备方法
CN106676160B (zh) * 2017-01-03 2020-02-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测泛酸的微孔板、其试剂盒及其制备方法
CN106676161B (zh) * 2017-01-03 2020-01-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测烟酸的微孔板、其试剂盒及其制备方法
CN106591415B (zh) * 2017-01-03 2019-12-10 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测生物素的微孔板、其试剂盒及其制备方法
EP3568076A4 (en) 2017-01-10 2020-10-21 Drawbridge Health, Inc. DEVICES, SYSTEMS AND METHODS FOR SAMPLING

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362830A (en) * 1966-04-04 1968-01-09 American Mach & Foundry Preparation of water soluble product
JPS57100177A (en) * 1980-12-16 1982-06-22 Showa Denko Kk Mixed agent composition of amino acid with saccharide
ZA854876B (en) * 1984-06-28 1986-08-27 Searle & Co Antacid composition
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
DE69004927T2 (de) * 1989-05-01 1994-06-30 Baxter Int Zusammensetzung eines heilmittels und verfahren zur verabreichung bei einer kontrollierten lösungsgeschwindigkeit.
DE3918051A1 (de) * 1989-06-02 1990-12-06 Haensel Otto Gmbh Verfahren zur satzweisen herstellung einer beluefteten suesswarenschaummasse aus einer zuckerloesung und einer aufschlagmittelloesung
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
JPH06182189A (ja) * 1991-05-31 1994-07-05 Res Corp Technol Inc 自己乳化型ガラス
JP3164854B2 (ja) * 1991-10-31 2001-05-14 雪印乳業株式会社 皮膚衛生用シート
CA2125148C (en) * 1991-12-05 1999-05-11 Siva N. Raman A carbohydrate glass matrix for the sustained release of a therapeutic agent
DE69216642T2 (de) * 1992-01-13 1997-05-07 Pfizer Verfahren zur herstellung von tabletten mit hoher festigkeit
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
WO1995032737A1 (en) * 1994-05-27 1995-12-07 Farmarc Nederland Bv Pharmaceutical composition

Also Published As

Publication number Publication date
KR19990022710A (ko) 1999-03-25
CN1245957C (zh) 2006-03-22
PT831790E (pt) 2003-07-31
SK167597A3 (en) 1998-10-07
CN1193908A (zh) 1998-09-23
IL122482A0 (en) 1998-06-15
EP0831790A2 (en) 1998-04-01
CA2223438A1 (en) 1996-12-19
AU6009896A (en) 1996-12-30
AP852A (en) 2000-06-16
NZ309841A (en) 1999-10-28
MX9709716A (es) 1998-03-31
HUP9901716A2 (hu) 1999-09-28
WO1996040077A3 (en) 1997-01-23
CZ391297A3 (cs) 1998-05-13
DE69628007D1 (de) 2003-06-12
AP9701151A0 (en) 1998-01-31
EP0831790B1 (en) 2003-05-07
AU713599B2 (en) 1999-12-09
JPH11506467A (ja) 1999-06-08
BR9609188A (pt) 1999-05-11
JP4502406B2 (ja) 2010-07-14
NO975773L (no) 1998-02-03
PL323902A1 (en) 1998-04-27
DE69628007T2 (de) 2003-11-27
HUP9901716A3 (en) 2000-04-28
CA2223438C (en) 2008-05-13
IL122482A (en) 1999-10-28
ATE239451T1 (de) 2003-05-15
WO1996040077A2 (en) 1996-12-19
PL184823B1 (pl) 2002-12-31
NO975773D0 (no) 1997-12-08
DK0831790T3 (da) 2003-09-01

Similar Documents

Publication Publication Date Title
ES2194992T3 (es) Procedimientos para la incorporacion estable de sustancias en matrices vitreas secas esponjosas, y composiciones asi obtenidas.
HN1999000075A (es) Agonistas y antagonistas il-2 selectivos
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
ES2195664T3 (es) Uso de fumaratos de dialquilo.
ES2162284T3 (es) Proceso para la fabricacion de tensioactivos que contienen grupos alquilo de cadena ramificada.
DK1131410T3 (da) Gensplejsede vævskonstruktioner og fremgangsmåde til fremstilling og anvendelse deraf
ES2100874T3 (es) Soporte para muestras de perfume.
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
BR9611401B1 (pt) 2-azetidinonas substituìdas com açúcar úteis como agentes hipocolesterolêmicos, composição farmacêutica e kit contendo as mesmas .
AR053383A2 (es) Celulas vegetales transformadas, plantas que las contienen y uso de una construccion de adn en un metodo
DE69905170T2 (de) Thiazolopyrimidinderivate
WO2002061111A3 (en) Room temperature stable competent cells
AR008991A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimientos para su preparacion y aplicacion de los mismos
ES2114198T3 (es) Placas de plastico celular obtenidas con empleo de propulsantes exentos de halogeno.
ES2167784T3 (es) Copolimeros reticulados a base de polimeros policarboxilicos.
MX9603607A (es) Matriz insecticida y su proceso de preparacion.
EE04685B1 (et) Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks
ES2147904T3 (es) Composicion de maltitol y su procedimiento de preparacion.
MX9802730A (es) Agonistas receptores hematopoyeticos multifuncionales.
BR9914437A (pt) Materiais e métodos para a modificação de polissacarìdeos de parede celular de planta
ES2129893T3 (es) Dinucleosido-5',5'-pirofosfatos.
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
BR0008035A (pt) Composições isoladas de células de planta e seu uso na modificação de sinalização de célula de planta
ES2153584T3 (es) Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos.
AR019499A1 (es) FORMULACIONES ANTIPARÁSITOS Y USO EN LA FABRICACIoN DE MEDICAMENTOS